Alcobra Pharma, an emerging company focused on the development of new medications to help patients with cognitive disorders, has announced financial results for the fourth quarter and fiscal year ended December 31, 2014, and provided a business update. The company reported ( (Dollar) 0.50) EPS for the quarter, beating the Thomson Reuters consensus estimate of ( (Dollar) 0.57) by (Dollar) 0.07. They set a 'buy' rating and a (Dollar) 10.00 price target on the stock. Analysts at Zacks downgraded ...
Read More
You have just read an article categorized health
titled Alcobra Pharma Announces Fourth Quarter and Fiscal Year 2014 Financial Results.
Written by:
editor -
Tuesday, February 17, 2015
There are currently no comments for "Alcobra Pharma Announces Fourth Quarter and Fiscal Year 2014 Financial Results"
Post a Comment